Back to Search
Start Over
A phase II study of first-line single agent of gefitinib in patients (pts) with stage IV non-small cell lung cancer (NSCLC)
- Source :
- Journal of Clinical Oncology. 23:7082-7082
- Publication Year :
- 2005
- Publisher :
- American Society of Clinical Oncology (ASCO), 2005.
-
Abstract
- 7082 Background: Gefitinib has shown modest activity in pts with recurrent NSCLC after platinum-based chemotherapy. However, the activity of gefitinib as first-line chemotherapy remains unknown. We...
- Subjects :
- Oncology
Recurrent NSCLC
Cancer Research
medicine.medical_specialty
Chemotherapy
business.industry
First line
medicine.medical_treatment
Phases of clinical research
Stage IV non-small cell lung cancer
respiratory tract diseases
Gefitinib
Internal medicine
medicine
heterocyclic compounds
Single agent
In patient
skin and connective tissue diseases
business
neoplasms
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........b77883684d3b146072eb888bafd6f8a2
- Full Text :
- https://doi.org/10.1200/jco.2005.23.16_suppl.7082